Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2009 Jul;15(7):844–850. doi: 10.1016/j.bbmt.2009.03.017

Table 1.

Patient Characteristics

Tac/Sir Tac/Sir/Mtx
N % N % p-value
Total 29 100 46 100
Age 0.80
 ≥50 20 69 33 72
 < 50 9 31 13 28
 median (range) 53 (29–64) 55 (20–69)
Sex 0.25
 M 17 59 33 72
 F 12 41 13 28
Patient-Donor Sex Matching 0.64
 MF 11 38 18 39
 MM 6 21 15 32
 FF 7 24 6 13
 FM 5 17 7 15
Prior Transplant 0.98
 Yes 10 34 16 35
 No 19 66 30 65
Diagnosis -
 AML 6 21 14 30
 Anemia/Red Cell Disorder - - 1 2
 CLL, SLL, PLL 3 10 7 15
 CML 3 10 2 4
 Hodgkin Disease 5 17 4 44
 MDS 1 3 8 17
 MM/Plasma Cell Disorder 2 7 2 4
 MPD - - 1 2
 NHL 9 31 7 15
Risk Status 0.37
 High Risk 12 41 11 24
 Low Risk* 17 59 35 76
*

Low risk defined as acute leukemia in CR1, de-novo MDS-RA or RARS, or first chronic phase CML. All others were considered high risk.